Annual Shareholders Equity
-$15.83 M
-$58.35 M-137.22%
December 31, 2023
Summary
- As of February 7, 2025, GYRE annual stockholders equity is -$15.83 million, with the most recent change of -$58.35 million (-137.22%) on December 31, 2023.
- During the last 3 years, GYRE annual shareholders equity has fallen by -$88.75 million (-121.70%).
- GYRE annual shareholders equity is now -121.70% below its all-time high of $72.92 million, reached on December 1, 2021.
Performance
GYRE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$63.18 M
+$2.83 M+4.69%
September 30, 2024
Summary
- As of February 7, 2025, GYRE quarterly stockholders equity is $63.18 million, with the most recent change of +$2.83 million (+4.69%) on September 30, 2024.
- Over the past year, GYRE quarterly shareholders equity has increased by +$79.01 million (+499.16%).
- GYRE quarterly shareholders equity is now -34.39% below its all-time high of $96.29 million, reached on March 1, 2023.
Performance
GYRE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
GYRE Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -137.2% | +499.2% |
| 3 y3 years | -121.7% | -34.4% |
| 5 y5 years | -121.7% | -34.4% |
GYRE Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -121.7% | at low | -34.4% | +499.2% |
| 5 y | 5-year | -121.7% | at low | -34.4% | +499.2% |
| alltime | all time | -121.7% | at low | -34.4% | +499.2% |
Gyre Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $63.18 M(+4.7%) |
| Jun 2024 | - | $60.35 M(+6.6%) |
| Mar 2024 | - | $56.64 M(-457.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -$15.83 M(-137.2%) | -$15.83 M(-116.4%) |
| Mar 2023 | - | $96.29 M |
| Dec 2022 | $42.52 M(-41.7%) | - |
| Dec 2021 | $72.92 M | - |
FAQ
- What is Gyre Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Gyre Therapeutics?
- What is Gyre Therapeutics annual shareholders equity year-on-year change?
- What is Gyre Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Gyre Therapeutics?
- What is Gyre Therapeutics quarterly shareholders equity year-on-year change?
What is Gyre Therapeutics annual stockholders equity?
The current annual shareholders equity of GYRE is -$15.83 M
What is the all time high annual shareholders equity for Gyre Therapeutics?
Gyre Therapeutics all-time high annual stockholders equity is $72.92 M
What is Gyre Therapeutics annual shareholders equity year-on-year change?
Over the past year, GYRE annual stockholders equity has changed by -$58.35 M (-137.22%)
What is Gyre Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of GYRE is $63.18 M
What is the all time high quarterly shareholders equity for Gyre Therapeutics?
Gyre Therapeutics all-time high quarterly stockholders equity is $96.29 M
What is Gyre Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, GYRE quarterly stockholders equity has changed by +$79.01 M (+499.16%)